Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab

Atypical hemolytic uremic syndrome (aHUS) is a rare, genetic, progressive, life-threatening form of thrombotic microangiopathy (TMA) predominantly caused by dysregulation of the alternative pathway of the complement system. Complement-amplifying conditions (CACs), including pregnancy complications [...

Descripción completa

Detalles Bibliográficos
Autores principales: Asif, Arif, Nayer, Ali, Haas, Christian S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437142/
https://www.ncbi.nlm.nih.gov/pubmed/27848226
http://dx.doi.org/10.1007/s40620-016-0357-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437142/
https://www.ncbi.nlm.nih.gov/pubmed/27848226
http://dx.doi.org/10.1007/s40620-016-0357-7

Ejemplares similares